Xiaodan Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiaodan Liu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
E. Jacobs Russell
1 shared publicationLingsheng Li
Medical Imaging Center, First Affiliated Hospital of Jinan University, Guangzhou, 510630, China
1 shared publicationMeng Li
Medical Imaging Center, First Affiliated Hospital of Jinan University, Guangzhou, 510630, China
1 shared publicationPing Ma
Department of Psychiatry, First Affiliated Hospital of Jinan University, Guangzhou, China
1 shared publicationS. Sta Maria Naomi
1 shared publicationWu Lin Sharon
1 shared publication
Latest Publications
- 1 February 2021
- Published by Elsevier in Psychiatry Research: Neuroimaging
- Vol. 308, 111239
Characterizing the subtype of anhedonia in major depressive disorder: A symptom-specific multimodal MRI study
- 1 February 2021
- Published by Elsevier in Psychiatry Research: Neuroimaging
- Vol. 308, 111239
Characterizing the subtype of anhedonia in major depressive disorder: A symptom-specific multimodal MRI study
- Open Access
- 1 January 2021
- Published by Aging and Disease in Aging and disease
- Vol. 12 (8) , 1977-2002
The Applications of Focused Ultrasound (FUS) in Alzheimer’s Disease Treatment: A Systematic Review on Both Animal and Human Studies
Alzheimer’s disease (AD) affects the basic ability to function and has imposed an immense burden on the community and health care system. Focused ultrasound (FUS) has recently been proposed as a novel noninvasive therapeutic approach for AD. However, systematic reviews on the FUS application in AD treatment have not been forthcoming. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) criteria to summarize the techniques associated with safety and efficacy, as well as possible underlying mechanisms of FUS effects on AD in animal and human studies. Animal studies demonstrated FUS with microbubbles (FUS-MB) induced blood-brain-barrier (BBB) opening that could facilitate various therapeutic agents entering the brain. Repeated FUS-MB and FUS stimulation can relieve AD pathology and improve cognitive and memory function. Human studies showed repeated FUS-MB are well tolerated with few adverse events and FUS stimulation could enhance local perfusion and neural function, which correlated with cognitive improvement. We conclude that FUS is a feasible and safe therapeutic and drug delivery strategy for AD. However, FUS treatment on humans is still in the early stages and requires further optimization and standardization.
- 1 January 2021
- Published by Aging and Disease in Aging and disease
- Vol. 12 (8) , 1977-2002
Open AccessThe Applications of Focused Ultrasound (FUS) in Alzheimer’s Disease Treatment: A Systematic Review on Both Animal and Human Studies
Alzheimer’s disease (AD) affects the basic ability to function and has imposed an immense burden on the community and health care system. Focused ultrasound (FUS) has recently been proposed as a novel noninvasive therapeutic approach for AD. However, systematic reviews on the FUS application in AD treatment have not been forthcoming. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) criteria to summarize the techniques associated with safety and efficacy, as well as possible underlying mechanisms of FUS effects on AD in animal and human studies. Animal studies demonstrated FUS with microbubbles (FUS-MB) induced blood-brain-barrier (BBB) opening that could facilitate various therapeutic agents entering the brain. Repeated FUS-MB and FUS stimulation can relieve AD pathology and improve cognitive and memory function. Human studies showed repeated FUS-MB are well tolerated with few adverse events and FUS stimulation could enhance local perfusion and neural function, which correlated with cognitive improvement. We conclude that FUS is a feasible and safe therapeutic and drug delivery strategy for AD. However, FUS treatment on humans is still in the early stages and requires further optimization and standardization.